Introduction
Silver nanoparticles have already found applications in different areas of study due to their unique features, such as optical, electrical, antibacterial, and thermal properties [1] [2] [3] [4] . There are different methods for obtaining silver nanoparticles, based on chemical reduction, biochemical processes in plants and bacteria, and ecofriendly methods [5, 6] . Their use as water-treatment agents and in membrane filtration processes also draws the scientific world's attention because of the wide-spectrum antimicrobial activity of silver nanoparticles, their costeffectiveness, and the low chance of toxic byproduct formation in comparison with traditional chemical watertreatment agents [7] [8] [9] . Medical applications of zero-valent silver nanoparticles include biosensors, biological tags, disinfectants, and antibacterial coatings for various medical instruments, catheters, and devices [10] [11] [12] [13] [14] [15] [16] . * Correspondence: sarvinazhajiyeva@gmail.com However, despite the wide-ranging benefits of using silver nanoparticles, there are also limitations in their medical applications [17] . There are still insufficient data on the safety of zero-valent silver nanoparticles for human use because the mechanisms of their action have not been thoroughly investigated. There are studies that show the toxicity of silver NPs not only on pathogenic cells but also on human cells, connected with the transition of Ag 0 ions to Ag + . Some researchers supposed that this problem could be solved by applying different coating materials (surfactants) or chelators [18, 19] .
Diazacrown ethers, as representatives of supramolecular compounds, are also promising antibacterial active substances because of their ionophoric features. Crown ethers can act as chelating agents and influence the properties of nanoparticles by chelating them, therefore making it possible to minimize the toxic and adverse effects of silver nanoparticles [20, 21] .
Considering all of these points, it was interesting to perform the chelation of silver nanoparticles by diazacrown-ether (DC) and compare their biological activity with that of pure silver nanoparticles and pure diazacrown-ether (DC).
Materials and methods

Fourier transform infrared (FTIR) spectroscopy
FTIR spectra of Ag@DC NPs were recorded on a Varian 3600 FTIR spectrophotometer in KBr tablets. The spectra were taken in the range of 4000-400 cm −1 at room temperature.
Ultraviolet-visible (UV-Vis) spectroscopy
The UV-spectra were recorded on a Varian Cary 50 UV-Vis spectrophotometer. UV spectra were recorded in the range of 220-400 nm of both ethanol solutions of DC and Ag@DC nanostructures.
Powder X-ray diffraction (XRD) analysis
XRD study was performed on a Rigaku Mini Flex 600 XRD diffractometer under ambient conditions. CuK α radiation from a Cu X-ray tube (15 mA; 30 kV) was used. The samples were scanned in the Bragg angle 2 theta range of 30 • to 80 • . 
7-ol (diazacrown ether or DC)
The synthesis of diazacrown was performed according to the procedure described by Hasanova et al. [20] . Yield of the product was 65%, mp 148-149 • C. Found: C 69. 5 
Synthesis of silver nanoparticles and nanosupramolecular ensemble Ag@DC
Ecofriendly and safe Ag 0 nanoparticles were obtained by a green synthesis method using starch [22] . To 30 mg of AgNO 3 was added 25 mg of starch, dissolved in 50 mL of distilled water. After that, 25% ammonia was added until the pH reached 11. The resulting solution was sonicated for 1 h with in an ice bath. Obtained nanoparticles were dried at ambient temperature. From the powder was prepared a solution in distilled water, to which the diazacrown-ether was added at a ratio of 2:1 with further ultrasonication for 15 min. Samples were investigated by FTIR, XRD, and TEM and their antibacterial activities were compared.
Transmission electron microscopy (TEM)
The TEM analysis of compounds and biological samples was performed on a TEM JEOL-1400.
Antibacterial studies
The antimicrobial activity of the Ag@DC ensemble was tested against bacterial strains (Acinetobacter baumannii BDU32, Escherichia coli BDU12, Klebsiella pneumoniae BDU44, Pseudomonas aeruginosa BDU49, and Staphylococcus aureus BDU23) by the twofold microdilution method (96-well microtiter assay). The bacterial strains were taken from the culture collection of the Department of Microbiology (Baku State University, Azerbaijan). In this assay, we used U-bottomed 96-well microtiter plates. The inoculum was prepared from a fresh colony on Muller Hinton medium ("Liofilchem") and bacterial strains (1 × 10 5 CFU) were inoculated into each well of the microplate, which contained active agents at different concentrations ranging from 256 to 2 µ g mL −1 for Ag and DC and 8 to 0.0625 µ g mL −1 for Ag@DC. The Ag 0 nanoparticles and Ag@DC were dissolved in distilled water and sonicated for 15 min (20 kHz, ampacity power 87%, 500 W). The DC sample was dissolved in distilled water without further sonication. The growth was determined by the resazurin method after 24 h of incubation at 37 • C; 30 µ L of resazurin solution (0.01%; Sigma Aldrich) was added to each well and the microplates were reincubated at 37 • C for about 4 h. If the color change from blue to pink, it indicated the growth of bacteria, and the minimum inhibitory concentration (MIC) was determined as the lowest concentration of the active agents that prevented this change in color [23, 24] .
Preparation of microbiological samples for TEM study
The influence of Ag 0 nanoparticles and the Ag@DC ensemble on the ultrastructural changes of E. coli BDU12 was investigated by TEM. E. coli BDU12 cells treated with 0.5 Ag@DC (0.5 µ g mL −1 Ag : 0.25 µ g mL −1 DC) and 0.25 Ag@DC (0.25 µ g mL −1 Ag : 0.125 µ g mL −1 DC) and untreated control E. coli BDU12 were incubated in a shaker (150 rpm) for 24 h at 37 • C. After that incubation, samples were centrifuged at 4500 rpm for 10 min. The resulting pellets were fixed in phosphate buffer solution (pH 7.4) containing 2% paraformaldehyde, 2% glutaraldehyde, and 0.1% picric acid. After postfixation procedures in 1% osmic acid solution for 1.5 h, Araldite-Epon blocks were prepared according to the generally accepted methods in electron microscopy [25] . Semithin sections (1-2 µ m) were obtained with a Leica EM UC7 ultramicrotome for further investigation by light microscope (Primo Star, Zeiss) and photographed with a digital camera (Canon D650).
Unstained ultrathin sections (50-60 nm) were examined under the JEM-1400 TEM at 80-120 kV. Morphometric analysis of the images (electronograms) was carried out in TIF format via a computer program (TEM Imaging Platform) developed by Olympus Soft Imaging Solutions GmbH (Germany).
Results
Synthesis of diazacrown ether was performed as shown in the Scheme. In the first stage of the synthesis, the condensation reaction of salicylaldehyde (1) was conducted with 1,2-ethylenediamine (2) in order to obtain the product N, N-ethylenebis(salicylimine) (3). The reduction of 3 was followed by the ring closure reaction of 4 with 1,3-dichloro-2-propanol, resulting in formation of the final product (5) .
Scheme. The synthesis of 7,8,14,15,16,17,18,19- [1, 5, 9, 12] dioxadiazacyclopentadecin-7-ol (diazacrown ether or DC).
The purity and crystalline properties of the Ag 0 nanoparticles were determined by powder XRD. The XRD patterns are shown in Figure 1 . All the XRD peaks were well defined and corresponded to Ag 0 nanoparticles with face-centered cubic structures. The peak broadening in the XRD pattern shows the formation of nanocrystals. In the pattern all lines relate to silver nanoparticles. The pattern has characteristic peaks at 38.3330 (111), 44.480 (200), 64.610 (220), and 77.310 (311) ( Table 1) and that correlates well with the standard pattern of silver nanoparticles. The intensity of the diffraction peak of the (111) plane is stronger than the other peaks. The average crystallite size, estimated from the (111) peak using the Williamson-Hall method, is 18.94 Å. (12) The spectrum of prepared nanostructures was compared with the spectrum of DC in order to determine the coordination sites of DC that may be involved in chelation with the surface of silver nanoparticles. In the UV-spectra of DC and Ag@DC are presented in Figure 3 . As can be seen, the characteristic peak of DC is shifted from 275 nm to 260 nm and that may be evidence of the silver nanoparticles' complexation with diazacrown ether.
In Figure 4 the TEM image and size distribution graph of the prepared Ag 0 NPs are presented. As seen from Figure 4 , the nanoparticles are homogeneous and the size of the nanostructures varies in the range of 10-18 nm.
The TEM image and size distribution graph of the prepared Ag@DC nanostructures are presented in Figure 5 . The nanostructures are also homogeneous and their size varies in the range of 8-18 nm.
The antibacterial activity of the synthesized active agents was studied against Acinetobacter baumannii BDU32, Escherichia coli BDU12, Klebsiella pneumoniae BDU44, Pseudomonas aeruginosa BDU49, and Staphylococcus aureus BDU23 by 96-well microtiter assay. As shown in Table 2 , the nanosupramolecular ensemble Ag@DC demonstrated greater antibacterial activity as compared with pure diazacrown-ether (DC) and
Ag 0 nanoparticles. Ag@DC showed high activity at the concentration of 2 µ g mL −1 . In this case, we need to decrease the concentration from 8 to 0.0625 µ g mL −1 for determining the MIC of this agent. The MIC of Ag@DC against both E. coli BDU12 and S. aureus BDU23 was 0.125 µ g mL −1 , whereas the antibacterial effect was significantly weaker in the case of Ag 0 nanoparticles (4; 64 µ g mL −1 ) and DC (64; 128 µ g mL −1 ). E. coli BDU12 and S. aureus BDU23 were more susceptible to Ag@DC than other strains. Ag@DC showed equal effect on A. baumannii BDU32, K. pneumoniae BDU44, and P. aeruginosa BDU49 (2 µ g mL −1 ). However, the MIC of Ag nanoparticles for A. baumannii BDU32 was 16 times higher and equal to 32 µ g mL −1 . In the case of K. pneumoniae BDU44 and P. aeruginosa BDU49, the difference between the MICs of zero-valent silver nanoparticles and Ag@DC was not so impressive, because the MIC of the Ag 0 nanoparticles for both strains was equal to 8 µ g mL −1 . E. coli, K. pneumoniae, and P. aeruginosa showed higher sensitivity toward Ag 0 nanoparticles in comparison with A. baumannii BDU32 and S. aureus BDU23. The inhibition activity of DC on K. pneumoniae BDU44 and P. aeruginosa BDU49 was 128 µ g mL −1 and against A. baumannii BDU44 was 64 µ g mL −1 . High sensitivity among the bacterial strains was not observed toward DC. In order to determine the passage and distribution mechanism of Ag@DC, TEM of Escherichia coli BDU12 was performed without and after treatment with active agents. The control untreated cells of E. coli BDU12 are shown in Figure 6 . In Figure 7 slight ultrastructural changes are shown, caused by nanostructures. Ag@DC was located mostly inside the cells. In Figure 8 it is shown that the ultrastructure of bacterial cells was strongly affected by the nanosupramolecular ensemble. As can be seen from this image, the disruption of the cells starts from inside the bacteria, where the nanostructures are mainly concentrated. There is no observed fragmentation of the cell wall of E. coli BDU12. In Figure 9 a ghost-cell of E. coli BDU12 is demonstrated without inner content. In this case, nanostructures are located in the deformed cell wall.
Discussion
According to these results, we can assume that Ag@DC is more effective than Ag 0 and DC against bacterial strains. The results of microbiological studies allow us to assume that the application of diazacrown ether as a chelating agent potentiates the antibacterial effects of silver nanoparticles on gram-positive and gram-negative bacteria. The synergistic effect of Ag@DC nanostructures can be explained by the ionophoric behavior of crown-ethers. Due to their ability to integrate inside the bacterial cell membrane, metal nanoparticles can pass through them inside the cell as if through a sieve.
As a result of the TEM study, it can be assumed that Ag@DC nanostructures perform their action after passing through the cell walls of the bacteria. The enormous difference of 32 times between MICs of Ag 0 nanoparticles and the Ag@DC nanosupramolecular ensemble is explained by the facilitated penetration of silver nanoparticles. A very interesting fact is that nanostructures are abundant inside the cells, indicating that silver nanoparticles in the ensemble are not oxidized to Ag + promptly after entering the bacteria. The TEM study of ultrastructural changes of treated E. coli BDU12, used as a representative of gram-negative bacteria, also shed The creation of new active agents on the basis of combining nanotechnology and supramolecular chemical approaches can help to overcome several problems in antimicrobial treatment. Our research shows that it is possible to significantly minimize (from 512 to 4 times in different strains) MICs of silver nanoparticles using the synergistic effect between them and diazacrown ether, which plays the role of a chelating agent. Thus, by chelating silver nanoparticles with a proper agent we can also decrease the therapeutic dose, and in this way reduce their toxicity and adverse effects. 
